Did you even read the conclusions of this PHASE 2 study on Sprifermin that your link referred to:
"Conclusions and relevance: Among participants with symptomatic radiographic knee osteoarthritis, the intra-articular administration of 100 μg of sprifermin every 6 or 12 months vs placebo resulted in an improvement in total femorotibial joint cartilage thickness after 2 years that was statistically significant, but of uncertain clinical importance; there was no significant difference for 30 μg of sprifermin every 6 or 12 months vs placebo. Durability of response also was uncertain."
Hardly seem like "competition" based on this study, if you have read any actual detail on the Paradigm PHASE 2 results.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Did you even read the conclusions of this PHASE 2 study on...
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.54M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21 | 20.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 670 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 21 | 0.205 |
4 | 31389 | 0.200 |
2 | 15564 | 0.195 |
17 | 416267 | 0.190 |
6 | 164843 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 3001 | 1 |
0.180 | 4001 | 1 |
0.190 | 670 | 2 |
0.200 | 4600 | 1 |
0.205 | 77468 | 3 |
Last trade - 09.30am 30/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
Day chart unavailable